Open Meeting Announcement - Glucose Monitors Proposed Local Coverage Determination (LCD) - JD DME
Open Meeting Announcement - Glucose Monitors Proposed Local Coverage Determination (LCD)
Posted October 6, 2022
On Tuesday, November 15, 2022 at 10 a.m. ET, the Durable Medical Equipment Medicare Administrative Contractors (DME MACs) will host a virtual public meeting to solicit stakeholder comments for the following proposed LCD:
Glucose Monitors (DL33822) - Proposing modifications to coverage criteria for continuous glucose monitors (CGMs)
This virtual meeting is for the oral presentation of comments and for stakeholders interested in listening to the comments. In order for any oral comments to be considered, they must be submitted in writing through the formal comment process. Information related to the written comment process is available at Proposed Local Coverage Determination (LCD) Released for Comment - Glucose Monitors
Stakeholders interested in attending the virtual meeting and commenting must register by Tuesday October 25, 2022 at 5 p.m. ET. Registration is available online at https://attendee.gotowebinar.com/register/5860445778760382734.
By registering, you consent to your comments being recorded at the virtual meeting. You must not include any protected health information (PHI) or personally identifiable information (PII) in your comments.
We request that you confine your public comments at the virtual open meeting to the proposed changes. The medical directors appreciate that you may have comments about other criteria in the proposed LCD, and you are welcome to submit those in your written comments; however, the virtual open meeting is to solicit public feedback on the proposed LCD changes. We ask that comments from the same organization/manufacturer be consolidated and presented by a single representative or spokesperson.
Any material (such as slides) that a registrant will present during the virtual open meeting must be sent to OpenMeetings@cgsadmin.com by Tuesday, November 1, 2022 at 5 p.m. ET. In the body of the email, please include the name of the presenter and the represented organization if applicable.
Advance registration is not required for stakeholders who only wish to listen to the virtual open meeting.
To access the virtual meeting via teleconference, use the following information:
Conference dial-in number:
US Toll free: 1-866-901-6455
Access Code: 289-296-342
Note: After joining the webinar, a telephone audio PIN will be provided to participants who registered to present oral comments.
The amount of time allotted for oral commenters' presentations will be determined by the number of commenters registered. Speaking time and order of commenters will be provided prior to the virtual meeting.
IMPORTANT REMINDER: Suppliers and clinicians are cautioned not to make any changes based upon information contained in a proposed LCD. The content of a proposed LCD may be revised based upon the written comments received during the comment period. When all written comments have been reviewed, revisions will be considered.
Refer to each DME MAC website for additional information, including access to the proposed LCDs.
Thank you for your participation in our policy development process.
Smitha M. Ballyamanda, MD, CAQSM
Medical Director, DME MAC Jurisdiction A
Noridian Healthcare Solutions, LLC
Sunil V. Lalla, MD, FACS, CPC
Medical Director, DME MAC Jurisdiction B
CGS Administrators, LLC
Robert D. Hoover, Jr., MD, MPH, FACP
Medical Director, DME MAC Jurisdiction C
CGS Administrators, LLC
Angela S. Jenny, DO
Medical Director, DME MAC, Jurisdiction D
Noridian Healthcare Solutions, LLC
